Workplace Fumes, Dust Could Raise Odds for Rheumatoid Arthritis
FRIDAY, Dec. 9, 2022 -- The air where you work could be increasing your risk of developing rheumatoid arthritis, a new study suggests.
Breathing in the fumes from commercial vapors, gases and solvents -- and even common dusts found in the workplace... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 9, 2022 Category: General Medicine Source Type: news
DMARDs for RA Improve Vascular Inflammation and CV Risk DMARDs for RA Improve Vascular Inflammation and CV Risk
Receipt of a tumor necrosis factor inhibitor or triple therapy for rheumatoid arthritis yielded an equally beneficial effect for reducing vascular inflammation and cardiovascular risk.Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - December 8, 2022 Category: Rheumatology Tags: Rheumatology News Source Type: news
Exposure to Occupational Inhalable Agents Could Increase RA Risk
WEDNESDAY, Dec. 7, 2022 -- Exposure to occupational inhalable agents is associated with an increased risk for anticitrullinated protein antibodies (ACPA)-positive rheumatoid arthritis (RA), according to a study published online Dec. 6 in the Annals... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 7, 2022 Category: Pharmaceuticals Source Type: news
DMARD Treatment and Differences in Disease Trajectory in RA DMARD Treatment and Differences in Disease Trajectory in RA
A new study looks at the changes in disease activity among rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs.Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 7, 2022 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Not Just a Miner's Problem: Workplace Fumes, Dust Tied to RA
(MedPage Today) -- Adding to previous studies implicating on-the-job exposure to silica dust as a risk factor for rheumatoid arthritis (RA), new research now finds dozens of other occupational inhalants that also appear to contribute to RA development... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - December 6, 2022 Category: Rheumatology Source Type: news
Cigna ’s PBM Express Scripts Latest To Put Less Pricey Biosimilars Of Abbvie’s Humira On Preferred Drug List
Cigna ’s pharmacy benefit manager Express Scripts will put “multiple" biosimilar versions of Abbvie’s expensive rheumatoid arthritis drug Humira in the “same position as the brand” on the PBM’s formulary in 2023. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 5, 2022 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma Source Type: news
Cardiovascular Risk Marker Improved With Common Rheumatoid Arthritis Drugs
(MedPage Today) -- Rheumatoid arthritis patients treated with medications targeting the tumor necrosis factor (TNF) pathway or with standard disease-modifying anti-rheumatic drugs (DMARDs) showed substantial reductions in arterial inflammation... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - December 2, 2022 Category: Rheumatology Source Type: news
Researchers Are Studying Whether Paxlovid Can Treat Long COVID
Months after catching COVID-19 in December 2021, Lavanya Visvabharathy was still testing positive on antigen tests and suffering from symptoms including headaches and intense fatigue. So Visvabharathy, a research assistant professor of neurology at the Northwestern University Feinberg School of Medicine who has studied Long COVID since 2020, decided to conduct an experiment on herself.
She asked her doctor to prescribe her Paxlovid, an antiviral therapy that can treat COVID-19 by inhibiting replication of the virus that causes it. Paxlovid is meant to keep high-risk patients with acute COVID-19 from developing severe disea...
Source: TIME: Health - November 29, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Benefits and Risks of Low-Dose, Add-On Prednisolone in Older Patients With Rheumatoid Arthritis
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - November 24, 2022 Category: Orthopaedics Tags: CME Article Source Type: news
ACR: Opioids Raise Risk for VTE in Patients With Rheumatoid Arthritis
MONDAY, Nov. 21, 2022 -- Opioid initiation among patients with rheumatoid arthritis (RA) is associated with similar major adverse cardiovascular events (MACE) and all-cause mortality risk versus nonsteroidal anti-inflammatory drug (NSAID)... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 21, 2022 Category: Pharmaceuticals Source Type: news
ACR: Holding Methotrexate for Just a Week After Flu Vaccine Works for RA Patients
FRIDAY, Nov. 18, 2022 -- For patients with rheumatoid arthritis (RA), temporarily discontinuing methotrexate for one week is noninferior to discontinuation for two weeks after seasonal flu vaccination to induce an immediate and long-term... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 18, 2022 Category: Pharmaceuticals Source Type: news
HCQ Doesn't Prevent or Delay Onset of Rheumatoid Arthritis HCQ Doesn't Prevent or Delay Onset of Rheumatoid Arthritis
A randomized clinical trial found that hydroxychloroquine was no more effective than placebo at preventing or delaying onset of rheumatoid arthritis.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 18, 2022 Category: Consumer Health News Tags: Rheumatology News Source Type: news
Opioids Increase Risk for All-Cause Deaths in RA vs. NSAIDs Opioids Increase Risk for All-Cause Deaths in RA vs. NSAIDs
The incidence of all-cause mortality was higher for patients with rheumatoid arthritis who started on opioids rather than NSAIDs for pain control.MDedge News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 18, 2022 Category: Cardiology Tags: Rheumatology News Source Type: news
Why Mark Cuban Is Selling Anti-Fungal Ointment for $7.34
Mark Cuban, the tech titan, Dallas Mavericks owner, and star of ABC’s Shark Tank, moves through the world like a friendly great white, all teeth and eyes and relentless motion. When we meet on an October morning at his office in the Mavericks’ headquarters, the serial entrepreneur, 64, is wearing a long-sleeved T-shirt advertising his last investment: Mark Cuban Cost Plus Drug Co. I was there to find out why a guy who’s made billions in tech, won an NBA championship, and become perhaps the most popular businessman on reality TV was spending his time and fortune hawking generic anti-fungal medications onli...
Source: TIME: Health - November 17, 2022 Category: Consumer Health News Authors: Charlotte Alter/Dallas Tags: Uncategorized Health Care Magazine uspoliticspolicy Source Type: news
UnitedHealth ’s Optum Rx To Coax Patients To Less Pricey Biosimilars Of Abbvie’s Humira
UnitedHealth Group ’s OptumRx will put biosimilar versions of Abbvie’s pricey rheumatoid arthritis drug Humira “in the same position as the brand” on the PBM’s formulary in 2023. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 15, 2022 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma Source Type: news
